Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients.

Autor: Herrscher H; Department of Medical Oncology, Centre Paul Strauss, 3, rue de la Porte de l'Hôpital, BP 30042, 67065, Strasbourg, Cedex, France., Velten M; Department of Epidemiology, Centre Paul Strauss, Strasbourg, France., Leblanc J; Department of Medical Oncology, Centre Paul Strauss, 3, rue de la Porte de l'Hôpital, BP 30042, 67065, Strasbourg, Cedex, France., Kalish-Weindling M; Department of Medical Oncology, Centre Paul Strauss, 3, rue de la Porte de l'Hôpital, BP 30042, 67065, Strasbourg, Cedex, France., Fischbach C; Department of Medical Oncology, Centre Paul Strauss, 3, rue de la Porte de l'Hôpital, BP 30042, 67065, Strasbourg, Cedex, France., Exinger D; Pharmacy, Centre Paul Strauss, Strasbourg, France., Pivot X; Department of Medical Oncology, Centre Paul Strauss, 3, rue de la Porte de l'Hôpital, BP 30042, 67065, Strasbourg, Cedex, France., Petit T; Department of Medical Oncology, Centre Paul Strauss, 3, rue de la Porte de l'Hôpital, BP 30042, 67065, Strasbourg, Cedex, France. tpetit@strasbourg.unicancer.fr.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jan; Vol. 179 (2), pp. 371-376. Date of Electronic Publication: 2019 Oct 14.

Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer.

Autor: Borel C; Medical Oncology Department, Centre Paul Strauss, Strasbourg, France.; Université de Strasbourg, Inserm IRFAC UMR_S1113, group « STREINTH », Strasbourg, France., Regnier-Gavier O; Pharmacy Department, Centre Paul Strauss, Strasbourg, France., Carinato H; Medical Oncology Department, Centre Paul Strauss, Strasbourg, France., Guihard S; Radiotherapy Department, Centre Paul Strauss, Strasbourg, France.; Université de Strasbourg, Inserm IRFAC UMR_S1113, group « STREINTH », Strasbourg, France., Antoni D; Radiotherapy Department, Centre Paul Strauss, Strasbourg, France.; Radiobiology Laboratory, Centre Paul Strauss, Université de Strasbourg, Strasbourg, France., Demarchi M; Medical Oncology Department, Centre Paul Strauss, Strasbourg, France., Sirlin F; Supportive Care Department, Centre Paul Strauss, Strasbourg, France., Exinger D; Pharmacy Department, Centre Paul Strauss, Strasbourg, France., Petit-Jean E; Pharmacy Department, Centre Paul Strauss, Strasbourg, France., Thiery A; Biostatistics Department, Centre Paul Strauss, Strasbourg, France., Bronner G; ENT Specialist, Strasbourg, France., Schultz P; ENT Specialist, Strasbourg, France.; Department of Otolaryngology Head and Neck Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Flesch H; ENT Specialist, Strasbourg, France., Frasie V; Supportive Care Department, Centre Paul Strauss, Strasbourg, France., Prébay D; Pharmacy Department, Centre Paul Strauss, Strasbourg, France., Petit T; Medical Oncology Department, Centre Paul Strauss, Strasbourg, France., Jung AC; Université de Strasbourg, Inserm IRFAC UMR_S1113, group « STREINTH », Strasbourg, France.; Tumor biology Laboratory, Centre Paul Strauss, Université de Strasbourg, Strasbourg, France., Burgy M; Medical Oncology Department, Centre Paul Strauss, Strasbourg, France., Coliat P; Pharmacy Department, Centre Paul Strauss, Strasbourg, France.; Université de Strasbourg, Inserm IRFAC UMR_S1113, group « STREINTH », Strasbourg, France.; Tumor biology Laboratory, Centre Paul Strauss, Université de Strasbourg, Strasbourg, France.

Publikováno v: Oncotarget [Oncotarget] 2018 Dec 25; Vol. 9 (101), pp. 37581-37588. Date of Electronic Publication: 2018 Dec 25 (Print Publication: 2018).

P524 COMPARISON OF DIFFERENT MODELS IN PREDICTING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION INCLUDING ELF-SCORE AND vWF-Ag

Autor: Maieron, A., Hametner, S., Ferlitsch, M., Etschmaier, A., Schoefl, R., Ziachehabi, A., Trubert-Exinger, D., Ferlitsch, A.

Publikováno v: In Journal of Hepatology April 2014 60(1) Supplement:S244-S245

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Apolipoprotein A and prognosis after myocardial infarction in non-diabetic men.

Autor: Pollak, H., Arnoldner, O., Enenkel, W., Fischer, M., Trubert-Exinger, D.

Publikováno v: Klinische Wochenschrift; Jan1991, Vol. 69 Issue 1, p10-15, 6p